T1-4 晚期前列腺癌患者的临床试验
总计412个结果
-
Tampere UniversityFinnish Prostate Cancer Group未知
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Sir Mortimer B. Davis - Jewish General Hospital招聘中
-
University of California, Irvine撤销
-
Novartis Pharmaceuticals完全的Prostate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated
-
Gustave Roussy, Cancer Campus, Grand Paris招聘中
-
Assiut University尚未招聘
-
Centre Georges Francois Leclerc尚未招聘
-
Shanghai Junshi Bioscience Co., Ltd.招聘中Patients With Advanced Malignant Tumors中国
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
Assistance Publique Hopitaux De Marseille完全的
-
University of Sao Paulo General Hospital未知本研究的重点是开发用于前列腺癌患者术后随访的应用程序
-
Prof. Dr. Cemil Tascıoglu Education and Research...完全的Patients With Closed Neer Type 4 Proximal Humerus Fractures火鸡
-
Azienda Ospedaliero-Universitaria Careggi完全的
-
University of Guelph-HumberUniversity Health Network, Toronto; McGill University Health Centre/Research Institute of the... 和其他合作者完全的
-
Lorenzo Livi未知与单独使用 AA 治疗的患者相比,接受 SBRT 联合醋酸阿比特龙 (AA) 的寡转移性 CRPC 的 PSA 反应率
-
Ferring Pharmaceuticals完全的
-
SCRI Development Innovations, LLCNovartis撤销